Adipokines as potential biomarkers in rheumatoid arthritis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Del Prete, Annalisa ^a,b   Salvi, Valentina ^a   Sozzani, Silvano ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; FINASTERIDE; RANTES;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PROSTATE; RHEUMATOID ARTHRITIS;

ADIPOKINES; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOKINE CCL5; FINASTERIDE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PROSTATE;

EID: 84899460897     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/425068     Document Type: Review

References (160)

1. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
2. Yudkin J. S., Stehouwer C. D. A., Emeis J. J., Coppack S. W., C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 972 978 2-s2.0-0032943709 (Pubitemid 29177345)
3. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K., Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology 2003 14 6 561 566 2-s2.0-0347334429 10.1097/00041433-200312000-00003 (Pubitemid 41623184)
4. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor-: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
5. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., Matsuzawa Y., Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 1996 2 7 800 803 2-s2.0-15844381594 10.1038/nm0796-800 (Pubitemid 26225097)
6. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
7. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
8. Bingham C. O. III, The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and imflammation. Journal of Rheumatology 2002 29 65 3 9 2-s2.0-0036730319 (Pubitemid 34988675)
9. Gómez R., Conde J., Scotece M., Gómez-Reino J. J., Lago F., Gualillo O., What's new in our understanding of the role of adipokines in rheumatic diseases? Nature Reviews Rheumatology 2011 7 9 528 536 2-s2.0-80052409973 10.1038/nrrheum.2011.107
10. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
11. Oh D. K., Ciaraldi T., Henry R. R., Adiponectin in health and disease. Diabetes, Obesity and Metabolism 2007 9 3 282 289 2-s2.0-33947663558 10.1111/j.1463-1326.2006.00610.x (Pubitemid 46502045)
12. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine 2007 13 3 332 339 2-s2.0-33847733103 10.1038/nm1557 (Pubitemid 46376688)
13. Deepa S. S., Dong L. Q., Appl1: role in adiponectin signaling and beyond. American Journal of Physiology. Endocrinology and Metabolism 2009 296 1 E22 E36 2-s2.0-58249105213 10.1152/ajpendo.90731.2008
14. Kadowaki T., Yamauchi T., Adiponectin receptor signaling: a new layer to the current model. Cell Metabolism 2011 13 2 123 124 2-s2.0-79551539872 10.1016/j.cmet.2011.01.012
15. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., Matsuzawa Y., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 8 1057 1063 2-s2.0-0035957040 (Pubitemid 32200177)
16. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., Maeda K., Nagaretani H., Kishida K., Maeda N., Nagasawa A., Funahashi T., Matsuzawa Y., Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages. Circulation 2004 109 17 2046 2049 2-s2.0-2442464884 10.1161/01.CIR.0000127953. 98131.ED (Pubitemid 38620209)
17. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A. J., Tomiyama Y., Matsuzawa Y., Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 96 5 1723 1732 2-s2.0-0034284038 (Pubitemid 30661055)
18. Turner J. J. O., Smolinska M. J., Sacre S. M., Foxwell B. M. J., Induction of TLR tolerance in human macrophages by adiponectin: does LPS play a role? Scandinavian Journal of Immunology 2009 69 4 329 336 2-s2.0-61849115061 10.1111/j.1365-3083.2008.02224.x
19. Ohashi K., Parker J. L., Ouchi N., Higuchi A., Vita J. A., Gokce N., Pedersen A. A., Kalthoff C., Tullin S., Sams A., Summer R., Walsh K., Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. Journal of Biological Chemistry 2010 285 9 6153 6160 2-s2.0-77949881805 10.1074/jbc.M109.088708
20. Holland W. L., Miller R. A., Wang Z. V., Sun K., Barth B. M., Bui H. H., Davis K. E., Bikman B. T., Halberg N., Rutkowski J. M., Wade M. R., Tenorio V. M., Kuo M.-S., Brozinick J. T., Zhang B. B., Birnbaum M. J., Summers S. A., Scherer P. E., Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine 2011 17 1 55 63 2-s2.0-78651260799 10.1038/nm.2277
21. Tong K.-M., Chen C.-P., Huang K.-C., Shieh D.-C., Cheng H.-C., Tzeng C.-Y., Chen K.-H., Chiu Y.-C., Tang C.-H., Adiponectin increases MMP-3 expression in human chondrocytes through adipor1 signaling pathway. Journal of Cellular Biochemistry 2011 112 5 1431 1440 2-s2.0-79953690517 10.1002/jcb.23059
22. Lago R., Gomez R., Otero M., Lago F., Gallego R., Dieguez C., Gomez-Reino J. J., Gualillo O., A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis and Cartilage 2008 16 9 1101 1109 2-s2.0-49149103250 10.1016/j.joca.2007.12.008
23. Gómez R., Scotece M., Conde J., Gómez-Reino J. J., Lago F., Gualillo O., Adiponectin and leptin increase IL-8 production in human chondrocytes. Annals of the Rheumatic Diseases 2011 70 11 2052 2054 2-s2.0-80053564876 10.1136/ard.2010.145672
24. Kusunoki N., Kitahara K., Kojima F., Tanaka N., Kaneko K., Endo H., Suguro T., Kawai S., Adiponectin stimulates prostaglandin E2 production in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism 2010 62 6 1641 1649 2-s2.0-77952950267 10.1002/art.27450
25. Kitahara K., Kusunoki N., Kakiuchi T., Suguro T., Kawai S., Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochemical and Biophysical Research Communications 2009 378 2 218 223 2-s2.0-57049158112 10.1016/j.bbrc.2008.11.017
26. Frommer K. W., Zimmermann B., Meier F. M. P., Schröder D., Heil M., Schäffler A., Büchler C., Steinmeyer J., Brentano F., Gay S., Müller-Ladner U., Neumann E., Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis and Rheumatism 2010 62 10 2886 2899 2-s2.0-77957355863 10.1002/art.27616
27. Giles J. T., Allison M., Bingham C. O. III, Scott W. M. Jr., Bathon J. M., Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Care and Research 2009 61 9 1248 1256 2-s2.0-69749093928 10.1002/art.24789
28. Otero M., Logo R., Gomez R., Logo F., Dieguez C., Gómez-Reino J. J., Gualillo O., Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006 65 9 1198 1201 2-s2.0-33747786726 10.1136/ard.2005.046540 (Pubitemid 44277396)
29. Schäffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Schölmerich J., Müller-Ladner U., Gay S., Adipocytokines in synovial fluid. Journal of the American Medical Association 2003 290 13 1709 1710 2-s2.0-0141816765 10.1001/jama.290.13.1709-c
30. Chen X., Lu J., Bao J., Guo J., Shi J., Wang Y., Adiponectin: a biomarker for rheumatoid arthritis? Cytokine & Growth Factor Reviews 2013 24 83 89
31. Klein-Wieringa I. R., van der Linden M. P. M., Knevel R., Kwekkeboom J. C., Van Beelen E., Huizinga T. W. J., Van Der Helm-Van Mil A., Kloppenburg M., Toes R. E. M., Ioan-Facsinay A., Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis and Rheumatism 2011 63 9 2567 2574 2-s2.0-80052314683 10.1002/art.30449
32. Nagashima T., Okubo-Fornbacher H., Aoki Y., Kamata Y., Kimura H., Kamimura T., Nara H., Iwamoto M., Yoshio T., Okazaki H., Minota S., Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. Journal of Rheumatology 2008 35 5 936 938 2-s2.0-44349111287 (Pubitemid 351747143)
33. Lewicki M., Kotyla P., Kucharz E., Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment. Journal of Rheumatology 2009 36 6 1346 1347 2-s2.0-67149089047 10.3899/jrheum.081192
34. Frommer K. W., Schaffler A., Buchler C., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis? Annals of the Rheumatic Diseases 2012 71 1724 1732
35. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425 432 (Pubitemid 24365442)
36. Ghilardi N., Skoda R. C., The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Molecular Endocrinology 1997 11 4 393 399 2-s2.0-0030956390 10.1210/me.11.4.393 (Pubitemid 27147006)
37. Frühbeck G., Intracellular signalling pathways activated by leptin. Biochemical Journal 2006 393 1 7 20 2-s2.0-30044434035 10.1042/BJ20051578 (Pubitemid 43049298)
38. Ahlma R. S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. S., Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 6588 250 252 2-s2.0-0029896530 10.1038/382250a0 (Pubitemid 26251358)
39. Jéquier E., Leptin signaling, adiposity, and energy balance. Annals of the New York Academy of Sciences 2002 967 379 388 2-s2.0-0036293591 (Pubitemid 34721923)
40. Gualillo O., Eiras S., Lago F., Diéguez C., Casanueva F. F., Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sciences 2000 67 20 2433 2441 2-s2.0-0034613023 10.1016/S0024-3205(00) 00827-4
41. Santos-Alvarez J., Goberna R., Sánchez-Margalet V., Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular Immunology 1999 194 1 6 11 2-s2.0-0033602850 10.1006/cimm.1999.1490 (Pubitemid 29283971)
42. Kiguchi N., Maeda T., Kobayashi Y., Fukazawa Y., Kishioka S., Leptin enhances CC-chemokine ligand expression in cultured murine macrophage. Biochemical and Biophysical Research Communications 2009 384 3 311 315 2-s2.0-65649141678 10.1016/j.bbrc.2009.04.121
43. Lord G. M., Matarese G., Howard J. K., Baker R. J., Bloom S. R., Lechler R. I., Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998 394 6696 897 901 2-s2.0-0032572722 10.1038/29795 (Pubitemid 28410912)
44. Faggioni R., Jones-Carson J., Reed D. A., Dinarello C. A., Feingold K. R., Grunfeld C., Fantuzzi G., Leptin-deficient (ob/ob) mice are protected from t cell-mediated hepatotoxicity: role of tumor necrosis factor and IL-18. Proceedings of the National Academy of Sciences of the United States of America 2000 97 5 2367 2372 2-s2.0-0034058378 10.1073/pnas.040561297 (Pubitemid 30134075)
45. Matarese G., di Giacomo A., Sanna V., Lord G. M., Howard J. K., Di Tuoro A., Bloom S. R., Lechler R. I., Zappacosta S., Fontana S., Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. Journal of Immunology 2001 166 10 5909 5916 2-s2.0-0035873418 (Pubitemid 32440714)
46. Lee S.-W., Park M.-C., Park Y.-B., Lee S.-K., Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatology International 2007 27 6 537 540 2-s2.0-33947137320 10.1007/s00296-006-0253-x (Pubitemid 46411889)
47. Yoshino T., Kusunoki N., Tanaka N., Kaneko K., Kusunoki Y., Endo H., Hasunuma T., Kawai S., Elevated serum levels of resistin, leptin, and adiponectin are associated with c-reactive protein and also other clinical conditions in rheumatoid arthritis. Internal Medicine 2011 50 4 269 275 2-s2.0-79951660109 10.2169/internalmedicine.50.4306
48. Hizmetli S., Kisa M., Gokalp N., Bakici M. Z., Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatology International 2007 27 4 335 338 2-s2.0-33846304699 10.1007/s00296-006-0264-7 (Pubitemid 46122275)
49. Busso N., So A., Chobaz-Péclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., Gabay C., Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. Journal of Immunology 2002 168 2 875 882 2-s2.0-0037080196 (Pubitemid 34049591)
50. Bernotiene E., Palmer G., Gabay C., The role of leptin in innate and adaptive immune responses. Arthritis Research and Therapy 2006 8 5, article 217 2-s2.0-33750812250 10.1186/ar2004 (Pubitemid 44712078)
51. Hultgren O. H., Tarkowski A., Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its adminstration. Arthritis Research 2001 3 6 389 394 2-s2.0-0035186628 10.1186/ar332 (Pubitemid 33080820)
52. Derdemezis C. S., Filippatos T. D., Voulgari P. V., Tselepis A. D., Drosos A. A., Kiortsis D. N., Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis. Fundamental and Clinical Pharmacology 2009 23 5 595 600 2-s2.0-69949166663 10.1111/j.1472-8206.2009.00717.x
53. Gonzalez-Gay M. A., Garcia-Unzueta M. T., Berja A., Gonzalez-Juanatey C., Miranda-Filloy J. A., Vazquez-Rodriguez T. R., Matias J. M. D., Martin J., Dessein P. H., Llorca J., Anti-TNF- therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clinical and Experimental Rheumatology 2009 27 2 222 228 2-s2.0-67249123828
54. Engvall I.-L., Tengstrand B., Brismar K., Hafström I., Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Arthritis Research and Therapy 2010 12 5, article R197 2-s2.0-77958030953 10.1186/ar3169
55. Olama S. M., Senna M. K., Elarman M., Synovial/Serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatology International 2012 32 683 690 2-s2.0-78649688822 10.1007/s00296-010-1698-5
56. Otero M., Lago R., Lago F., Reino J. J. G., Gualillo O., Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Research & Therapy 2005 7 3 R581 591 2-s2.0-30344486078
57. Otero M., Lago R., Gómez R., Lago F., Gomez-Reino J. J., Gualillo O., Phosphatidylinositol 3-kinase, MEK-1 and p38 mediate leptin/interferon-gamma synergistic NOS type II induction in chondrocytes. Life Sciences 2007 81 19-20 1452 1460 2-s2.0-35548979409 10.1016/j.lfs.2007.09.007 (Pubitemid 350018780)
58. Bao J.-P., Chen W.-P., Feng J., Hu P.-F., Shi Z.-L., Wu L.-D., Leptin plays a catabolic role on articular cartilage. Molecular Biology Reports 2010 37 7 3265 3272 2-s2.0-77956946117 10.1007/s11033-009-9911-x
59. Tong K.-M., Shieh D.-C., Chen C.-P., Tzeng C.-Y., Wang S.-P., Huang K.-C., Chiu Y.-C., Fong Y.-C., Tang C.-H., Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF- B/p300 binding in human synovial fibroblasts. Cellular Signalling 2008 20 8 1478 1488 2-s2.0-45449105340 10.1016/j.cellsig.2008.04.003
60. Lam Q. L. K., Lu L., Role of leptin in immunity. Cellular & Molecular Immunology 2007 4 1 1 13 2-s2.0-34249697436
61. Lam Q. L. K., Zheng B.-J., Jin D.-Y., Cao X., Lu L., Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. Journal of Biological Chemistry 2007 282 38 27587 27597 2-s2.0-34948818333 10.1074/jbc.M704579200 (Pubitemid 47529530)
62. + regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5150 5155 2-s2.0-17044381726 10.1073/pnas.0408995102
63. de Rosa V., Procaccini C., Calì G., Pirozzi G., Fontana S., Zappacosta S., La Cava A., Matarese G., A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007 26 2 241 255 2-s2.0-33847312289 10.1016/j.immuni.2007.01.011 (Pubitemid 46329441)
64. Notley C. A., Ehrenstein M. R., The yin and yang of regulatory T cells and inflammation in RA. Nature Reviews Rheumatology 2010 6 10 572 577 2-s2.0-77957552569 10.1038/nrrheum.2010.143
65. Procaccini C., de Rosa V., Galgani M., Abanni L., Calì G., Porcellini A., Carbone F., Fontana S., Horvath T. L., La Cava A., Matarese G., An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010 33 6 929 941 2-s2.0-78650188983 10.1016/j.immuni.2010.11.024
66. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M., Teng M., Duvic M., Chandraratna R. A. S., Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. Journal of Investigative Dermatology 1997 109 1 91 95 2-s2.0-0030847171 (Pubitemid 27305655)
67. Wittamer V., Franssen J.-D., Vulcano M., Mirjolet J.-F., Le Poul E., Migeotte I., Brézillon S., Tyldesley R., Blanpain C., Detheux M., Mantovani A., Sozzani S., Vassart G., Parmentier M., Communi D., Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 2003 198 7 977 985 2-s2.0-0141993969 10.1084/jem.20030382 (Pubitemid 37248614)
68. Wittamer V., Grégoire F., Robberecht P., Vassart G., Communi D., Parmentier M., The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. Journal of Biological Chemistry 2004 279 11 9956 9962 2-s2.0-1642389889 10.1074/jbc.M313016200 (Pubitemid 38372597)
69. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., Vecchi A., Franssen J.-D., Communi D., Massardi L., Sironi M., Mantovani A., Parmentier M., Facchetti F., Sozzani S., Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. Journal of Experimental Medicine 2005 201 4 509 515 2-s2.0-20044369873 10.1084/jem.20041310 (Pubitemid 40289541)
70. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., Sozzani S., The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007 109 9 3625 3632 2-s2.0-34247373833 10.1182/blood-2006-08-038844 (Pubitemid 46641708)
71. Zabel B. A., Ohyama T., Zuniga L., Kim J.-Y., Johnston B., Allen S. J., Guido D. G., Handel T. M., Butcher E. C., Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF- β and TLR ligands. Experimental Hematology 2006 34 8 1106 1114 2-s2.0-33746072310 10.1016/j.exphem.2006.03.011 (Pubitemid 44080376)
72. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., Fortugno P., Gonzalvo-Feo S., Franssen J.-D., Parmentier M., De Pità O., Girolomoni G., Sozzani S., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. Journal of Experimental Medicine 2009 206 1 249 258 2-s2.0-60549117538 10.1084/jem.20080129
73. Parlee S. D., Ernst M. C., Muruganandan S., Sinal C. J., Goralski K. B., Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor- Endocrinology 2010 151 6 2590 2602 2-s2.0-77954478378 10.1210/en.2009-0794
74. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D., Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 148 10 4687 4694 2-s2.0-34748817386 10.1210/en.2007-0175 (Pubitemid 47481514)
75. Lehrke M., Becker A., Greif M., Stark R., Laubender R. P., Von Ziegler F., Lebherz C., Tittus J., Reiser M., Becker C., Göke B., Leber A. W., Parhofer K. G., Broedl U. C., Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology 2009 161 2 339 344 2-s2.0-68349146816 10.1530/EJE-09-0380
76. Jialal I., Devaraj S., Kaur H., Adams-Huet B., Bremer A. A., Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2013 98 E514 E517
77. Ernst M. C., Haidl I. D., Zuńĩga L. A., Dranse H. J., Rourke J. L., Zabel B. A., Butcher E. C., Sinal C. J., Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012 153 2 672 682 2-s2.0-84856107177 10.1210/en.2011-1490
78. Berg V., Sveinbjörnsson B., Bendiksen S., Brox J., Meknas K., Figenschau Y., Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157. Arthritis Research and Therapy 2010 12 6, article R228 2-s2.0-78650591267 10.1186/ar3215
79. Kaneko K., Miyabe Y., Takayasu A., Fukuda S., Miyabe C., Ebisawa M., Yokoyama W., Watanabe K., Imai T., Muramoto K., Terashima Y., Sugihara T., Matsushima K., Miyasaka N., Nanki T., Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Research and Therapy 2011 13 5, article R158 2-s2.0-80053175351 10.1186/ar3475
80. Ha Y. J., Kang E. J., Song J. S., Park Y. B., Lee S. K., Choi S. T., Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Joint Bone Spine 2013
81. Herenius M. M., Oliveira A. S., Wijbrandts C. A., Gerlag D. M., Tak P. P., Lebre M. C., Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS ONE 2013 8 e57802
82. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I., Cloning and characterization of the cDNA encoding a novel human pre-B- cell colony-enhancing factor. Molecular and Cellular Biology 1994 14 2 1431 1437 2-s2.0-0027958452
83. Friebe D., Neef M., Kratzsch J., Erbs S., Dittrich K., Garten A., Petzold-Quinque S., Blüher S., Reinehr T., Stumvoll M., Blüher M., Kiess W., Körner A., Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011 54 5 1200 1211 2-s2.0-79954634068 10.1007/s00125-010-2042-z
84. Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramírez B., Silva C., Rotellar F., Cienfuegos J. A., Salvador J., Frühbeck G., Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 4 245 253 2-s2.0-79952702085 10.1016/j.numecd.2009.09.008
85. Curat C. A., Wegner V., Sengenès C., Miranville A., Tonus C., Busse R., Bouloumié A., Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 49 4 744 747 2-s2.0-33644826101 10.1007/s00125-006-0173-z (Pubitemid 43357549)
86. Jia S. H., Li Y., Parodo J., Kapus A., Fan L., Holstein O. D., Marshall J. C., Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation 2004 113 9 1318 1327 2-s2.0-2342650912 10.1172/JCI200419930 (Pubitemid 39069931)
87. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005 307 5708 426 430 2-s2.0-19944433652 10.1126/science.1097243 (Pubitemid 40139988)
88. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Erratum (Retracted article): Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2007 318 5850 565 2-s2.0-35548934694 (Pubitemid 350014814)
89. Jacques C., Holzenberger M., Mladenovic Z., Salvat C., Pecchi E., Berenbaum F., Gosset M., Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity. Journal of Biological Chemistry 2012 287 18 15100 15108 2-s2.0-84860356619 10.1074/jbc.M112.350215
90. Haider D. G., Schindler K., Schaller G., Prager G., Wolzt M., Ludvik B., Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism 2006 91 4 1578 1581 2-s2.0-33646052892 10.1210/jc.2005-2248
91. Moschen A. R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., Tilg H., Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology 2007 178 3 1748 1758 2-s2.0-33846527541 (Pubitemid 46154646)
92. Lee W.-J., Wu C.-S., Lin H., Lee I.-T., Wu C.-M., Tseng J.-J., Chou M.-M., Sheu W. H.-H., Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-B pathway. International Journal of Obesity 2009 33 4 465 472 2-s2.0-64849099945 10.1038/ijo.2009.24
93. Dahl T. B., Yndestad A., Skjelland M., Øie E., Dahl A., Michelsen A., Damås J. K., Tunheim S. H., Ueland T., Smith C., Bendz B., Tonstad S., Gullestad L., Frøland S. S., Krohg-Sørensen K., Russell D., Aukrust P., Halvorsen B., Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007 115 8 972 980 2-s2.0-33847279330 10.1161/CIRCULATIONAHA.106.665893 (Pubitemid 46328290)
94. Nowell M. A., Richards P. J., Fielding C. A., Ognjanovic S., Topley N., Williams A. S., Bryant-Greenwood G., Jones S. A., Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism 2006 54 7 2084 2095 2-s2.0-33745894354 10.1002/art.21942 (Pubitemid 44051064)
95. Brentano F., Schorr O., Ospelt C., Stanczyk J., Gay R. E., Gay S., Kyburz D., Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis and Rheumatism 2007 56 9 2829 2839 2-s2.0-34848847894 10.1002/art.22833 (Pubitemid 47502729)
96. Matsui H., Tsutsumi A., Sugihara M., Suzuki T., Iwanami K., Kohno M., Goto D., Matsumoto I., Ito S., Sumida T., Visfatin (pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2008 67 4 571 572 2-s2.0-41849119173 10.1136/ard.2007.077578 (Pubitemid 351498444)
97. Meier F. M., Frommer K. W., Peters M. A., Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis. Journal of Biological Chemistry 2012 287 28378 28385
98. Evans L., Williams A. S., Hayes A. J., Jones S. A., Nowell M., Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. Arthritis and Rheumatism 2011 63 7 1866 1877 2-s2.0-79959823404 10.1002/art.30338
99. Busso N., Karababa M., Nobile M., Rolaz A., Van Gool F., Galli M., Leo O., So A., De Smedt T., Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS ONE 2008 3 5 2-s2.0-48249105497 10.1371/journal.pone.0002267 e2267
100. Rho Y.H., Solus J., Sokka T., Oeser A., Chung C. P., Gebretsadik T., Shintani A., Pincus T., Stein C. M., Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis and Rheumatism 2009 60 7 1906 1914 2-s2.0-67650066805 10.1002/art.24626
101. Gonzalez-Gay M. A., Vazquez-Rodriguez T. R., Garcia-Unzueta M. T., Berja A., Miranda-Filloy J. A., De Matias J. M., Gonzalez-Juanatey C., Llorca J., Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF- therapy. Clinical and Experimental Rheumatology 2010 28 1 56 62 2-s2.0-77949508778
102. Šenolt L., Kryštůfková O., Hulejová H., Kuklová M., Filková M., Cerezo L. A., Běláč ek J., Haluzík M., Forejtová Š., Gay S., Pavelka K., Vencovský J., The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy. Cytokine 2011 55 1 116 121 2-s2.0-79956360551 10.1016/j.cyto.2011.04.004
103. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
104. Heilbronn L. K., Rood J., Janderova L., Albu J. B., Kelley D. E., Ravussin E., Smith S. R., Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2004 89 4 1844 1848 2-s2.0-1942504927 10.1210/jc.2003-031410 (Pubitemid 38507943)
105. Lee J. H., Chan J. L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., Mantzoros C. S., Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 10 4848 4856 2-s2.0-0242320395 10.1210/jc.2003-030519 (Pubitemid 37357535)
106. Tarkowski A., Bjersing J., Shestakov A., Bokarewa M. I., Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. Journal of Cellular and Molecular Medicine 2010 14 6 B 1419 1431 2-s2.0-77955136041 10.1111/j.1582-4934.2009.00899.x
107. Son Y. M., Ahn S. M., Kim G. R., Moon Y. S., Kim S. H., Park Y.-M., Lee W. K., Min T. S., Han S. H., Yun C.-H., Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells. BMC Immunology 2010 11, article 33 2-s2.0-77954052792 10.1186/1471-2172-11-33
108. Kaser S., Kaser A., Sandhofer A., Ebenbichler C. F., Tilg H., Patsch J. R., Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochemical and Biophysical Research Communications 2003 309 2 286 290 2-s2.0-0042925580 10.1016/j.bbrc.2003.07.003 (Pubitemid 37025889)
109. Silswal N., Singh A. K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N. Z., Human resistin stimulates the pro-inflammatory cytokines TNF- and IL-12 in macrophages by NF- B-dependent pathway. Biochemical and Biophysical Research Communications 2005 334 4 1092 1101 2-s2.0-23044439100 10.1016/j.bbrc.2005.06. 202 (Pubitemid 41074686)
110. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A., Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology 2005 174 9 5789 5795 2-s2.0-17844392652 (Pubitemid 40593223)
111. Fadda S. M., Gamal S. M., Elsaid N. Y., Mohy A. M., Resistin in inflammatory and degenerative rheumatologic diseases: relationship between resistin and rheumatoid arthritis disease progression. Zeitschrift für Rheumatologie 2013 72 594 600
112. Šenolt L., Housa D., Vernerová Z., Jirásek T., Svobodová R., Veigl D., Anderlová K., Müller-Ladner U., Pavelka K., Haluzík M., Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Annals of the Rheumatic Diseases 2007 66 4 458 463
113. Migita K., Maeda Y., Miyashita T., Kimura H., Nakamura M., Ishibashi H., Eguchi K., The serum levels of resistin in rheumatoid arthritis patients. Clinical and Experimental Rheumatology 2006 24 6 698 701 2-s2.0-33846438219 (Pubitemid 46138804)
114. Forsblad Delia H., Pullerits R., Carlsten H., Bokarewa M., Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology 2008 47 7 1082 1087 2-s2.0-45749086908 10.1093/rheumatology/ken187 (Pubitemid 351865939)
115. Kontunen P., Vuolteenaho K., Nieminen R., Lehtimäki L., Kautiainen H., Kesäniemi Y. A., Ukkola O., Kauppi M., Hakala M., Moilanen E., Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis. Scandinavian Journal of Rheumatology 2011 40 4 256 262 2-s2.0-80052009577 10.3109/03009742.2010.548827
116. Straburzyńska-Lupa A., Nowak A., Pilaczyńska- Szcześniak Ł., Straburzyńska-Migaj E., Romanowski W., Karolkiewicz J., Śliwicka E., Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clinical and Experimental Rheumatology 2010 28 1 19 24 2-s2.0-77949536865
117. Alkady E. A. M., Ahmed H. M., Tag L., Abdou M. A., Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity. Zeitschrift für Rheumatologie 2011 70 7 602 608 2-s2.0-84155167798 10.1007/s00393-011-0834-2
118. Gonzalez-Gay M. A., Garcia-Unzueta M. T., Gonzalez-Juanatey C., Miranda-Filloy J. A., Vazquez-Rodriguez T. R., de Matias J. M., Martin J., Dessein P. H., Llorca J., Anti-TNF- therapy modulates resistin in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2008 26 2 311 316 2-s2.0-43349098447 (Pubitemid 351659139)
119. Klaasen R., Herenius M. M. J., Wijbrandts C. A., de Jager W., van Tuyl L. H., Nurmohamed M. T., Prakken B. J., Gerlag D. M., Tak P. P., Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Annals of the Rheumatic Diseases 2012 71 1510 1516 2-s2.0-84858725710 10.1136/annrheumdis-2011-200646
120. Triebel S., Blaser J., Reinke H., Tschesche H., A 25 kDa 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Letters 1992 314 3 386 388 2-s2.0-0026746638 10.1016/0014-5793(92)81511-J (Pubitemid 23005695)
121. Borregaard N., Cowland J. B., Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. BioMetals 2006 19 2 211 215 2-s2.0-33646947821 10.1007/s10534-005-3251-7 (Pubitemid 43794830)
122. Chakraborty S., Kaur S., Guha S., Batra S. K., The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica et Biophysica Acta. Reviews on Cancer 2012 1826 1 129 169 2-s2.0-84860222365 10.1016/j.bbcan.2012.03.008
123. Hvidberg V., Jacobsen C., Strong R. K., Cowland J. B., Moestrup S. K., Borregaard N., The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Letters 2005 579 3 773 777 2-s2.0-12744272449 10.1016/j.febslet.2004.12.031
124. Flower D. R., The lipocalin protein family: structure and function. Biochemical Journal 1996 318 1 1 14 2-s2.0-0029790266 (Pubitemid 26283618)
125. Chu S.-T., Lin H.-J., Huang H.-L., Chen Y.-H., The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. Journal of Peptide Research 1998 52 5 390 397 2-s2.0-0032418327 (Pubitemid 29018333)
126. Yang J., Goetz D., Li J.-Y., Wang W., Mori K., Setlik D., Du T., Erdjument-Bromage H., Tempst P., Strong R., Barasch J., An iron delivery pathway mediated by a lipocalin. Molecular Cell 2002 10 5 1045 1056 2-s2.0-18744397511 10.1016/S1097-2765(02)00710-4 (Pubitemid 35453824)
127. Liu Z., Yang A., Wang Z., Bunting K. D., Davuluri G., Green M. R., Devireddy L. R., Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3. Journal of Biological Chemistry 2011 286 20606 20614
128. Goetz D. H., Holmes M. A., Borregaard N., Bluhm M. E., Raymond K. N., Strong R. K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Molecular Cell 2002 10 5 1033 1043 2-s2.0-0036865552 10.1016/S1097-2765(02)00708-6 (Pubitemid 36001971)
129. Liu Z., Petersen R., Devireddy L., Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. Journal of Immunology 2013 190 4692 4706
130. Jiang W., Constante M., Santos M. M., Anemia upregulates lipocalin 2 in the liver and serum. Blood Cells, Molecules, and Diseases 2008 41 2 169 174 2-s2.0-48949083720 10.1016/j.bcmd.2008.04.006
131. Yan Q.-W., Yang Q., Mody N., Graham T. E., Hsu C.-H., Xu Z., Houstis N. E., Kahn B. B., Rosen E. D., The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007 56 10 2533 2540 2-s2.0-34948856953 10.2337/db07-0007 (Pubitemid 47523260)
132. Cowland J. B., Muta T., Borregaard N., IL-1 β -specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by I B- ζ Journal of Immunology 2006 176 9 5559 5566 2-s2.0-33646006080
133. Owen H. C., Roberts S. J., Ahmed S. F., Farquharson C., Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. American Journal of Physiology. Endocrinology and Metabolism 2008 294 6 E1023 E1034 2-s2.0-47549111931 10.1152/ajpendo.00586.2007
134. Conde J., Gomez R., Bianco G., Scotece M., Lear P., Dieguez C., Gomez-Reino J., Lago F., Gualillo O., Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Annals of the Rheumatic Diseases 2011 70 3 551 559 2-s2.0-79951511147 10.1136/ard.2010.132399
135. Tschesche H., Zölzer V., Triebel S., Bartsch S., The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. European Journal of Biochemistry 2001 268 7 1918 1928 2-s2.0-0034858149 10.1046/j.1432-1327.2001.02066.x (Pubitemid 32852933)
136. Gruber B. L., Sorbi D., French D. L., Marchese M. J., Nuovo G. J., Kew R. R., Arbeit L. A., Markedly elevated serum MMP-9 (Gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clinical Immunology and Immunopathology 1996 78 2 161 171 2-s2.0-0030007885 10.1006/clin.1996.0025 (Pubitemid 26084595)
137. Katano M., Okamoto K., Arito M., Kawakami Y., Kurokawa M. S., Suematsu N., Shimada S., Nakamura H., Xiang Y., Masuko K., Nishioka K., Yudoh K., Kato T., Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Research and Therapy 2009 11 1, article R3 2-s2.0-60849125396 10.1186/ar2587
138. Uhlar C. M., Whitehead A. S., Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 1999 265 2 501 523 2-s2.0-0033569982 10.1046/j.1432-1327.1999.00657.x (Pubitemid 29488982)
139. Reigstad C. S., Lundén G. Ö., Felin J., Bäckhed F., Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 2009 4 6 2-s2.0-67649225408 10.1371/journal.pone.0005842 e5842
140. Frasshauer M., Klein J., Kralisch S., Klier M., Lossner U., Bluher M., Paschke R., Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. Journal of Endocrinology 2004 183 3 561 567 2-s2.0-11244318370 10.1677/joe.1.05699 (Pubitemid 40057586)
141. Lin Y., Rajala M. W., Berger J. P., Moller D. E., Barzilai N., Scherer P. E., Hyperglycemia-induced production of acute phase reactants in adipose tissue. Journal of Biological Chemistry 2001 276 45 42077 42083 2-s2.0-0035834630 10.1074/jbc.M107101200 (Pubitemid 37371113)
142. Chang Y. H., Subramanian S., Chan C. K., Omer M., Chiba T., Wight T. N., Chait A., Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 2007 56 9 2260 2273 2-s2.0-34548402222 10.2337/db07-0218 (Pubitemid 47358233)
143. Son D.-S., Arai K. Y., Roby K. F., Terranova P. F., Tumor Necrosis Factor (TNF) increases granulosa cell proliferation: dependence on c-Jun and TNF receptor type 1. Endocrinology 2004 145 3 1218 1226 2-s2.0-1442299148 10.1210/en.2003-0860 (Pubitemid 38281003)
144. Deguchi A., Tomita T., Omori T., Serum amyloid A3 binds MD-2 to activate p38 and NF- κ B pathways in a MyD88-dependent manner. Journal of Immunology 2013 191 1856 1864
145. Vallon R., Freuler F., Desta-Tsedu N., Robeva A., Dawson J., Wenner P., Engelhardt P., Boes L., Schnyder J., Tschopp C., Urfer R., Baumann G., Serum amyloid a (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. Journal of Immunology 2001 166 4 2801 2807 2-s2.0-0035865212 (Pubitemid 32173521)
146. Geurts J., Vermeij E. A., Pohlers D., Arntz O. J., Kinne R. W., Van Den Berg W. B., Van De Loo F. A. J., A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts. Annals of the Rheumatic Diseases 2011 70 7 1311 1319 2-s2.0-79957655546 10.1136/ard.2010.135665
147. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., Hashimoto I., Okada T., Yasuhara A., Nakatsuka A., Shikata K., Hourai S., Futami J., Watanabe E., Matsuki Y., Hiramatsu R., Akagi S., Makino H., Kanwar Y. S., Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proceedings of the National Academy of Sciences of the United States of America 2005 102 30 10610 10615 2-s2.0-23044473651 10.1073/pnas.0504703102 (Pubitemid 41061602)
148. Klöting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schön M. R., Stumvoll M., Blüher M., Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochemical and Biophysical Research Communications 2006 339 1 430 436 2-s2.0-28144450841 10.1016/j.bbrc.2005.11.039 (Pubitemid 41697566)
149. Ozgen M., Koca S. S., Dagli N., Balin M., Ustundag B., Isik A., Serum adiponectin and vaspin levels in rheumatoid arthritis. Archives of Medical Research 2010 41 6 457 463 2-s2.0-78049418187 10.1016/j.arcmed.2010.08.012
150. Šenolt L., Polanská M., Filková M., Cerezo L. A., Pavelka K., Gay S., Haluzík M., Vencovský J., Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases 2010 69 7 1410 1411 2-s2.0-77954972021 10.1136/ard.2009.119735
151. Schäffler A., Neumeier M., Herfarth H., Fürst A., Schölmerich J., Büchler C., Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et Biophysica Acta. Gene Structure and Expression 2005 1732 1-3 96 102 2-s2.0-33144479356 10.1016/j.bbaexp.2005.11.005 (Pubitemid 43267310)
152. de Souza Batista C. M., Yang R.-Z., Lee M.-J., Glynn N. M., Yu D.-Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried S. K., Gong D.-W., Shuldiner A. R., Pollin T. I., McLenithan J. C., Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007 56 6 1655 1661 2-s2.0-34249674520 10.2337/db06-1506 (Pubitemid 46842600)
153. Cantarini L., Simonini G., Fioravanti A., Generoso M., Bacarelli M. R., Dini E., Galeazzi M., Cimaz R., Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity. Clinical and Experimental Rheumatology 2011 29 1044 1048
154. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.-X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M., Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 1998 251 2 471 476 2-s2.0-0032552988 10.1006/bbrc.1998.9489 (Pubitemid 28505047)
155. Boucher J., Masri B., Daviaud D., Gesta S., Guigné C., Mazzucotelli A., Castan-Laurell I., Tack I., Knibiehler B., Carpé né C., Audigier Y., Saulnier-Blache J.-S., Valet P., Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005 146 4 1764 1771 2-s2.0-20144380036 10.1210/en.2004-1427 (Pubitemid 40396885)
156. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., Ayav A., Ziegler O., Carpene C., Saulnier-Blache J.-S., Valet P., Castan-Laurell I., TNFalpha up-regulates apelin expression in human and mouse adipose tissue. The FASEB Journal 2006 20 9 1528 1530 2-s2.0-33746498025 10.1096/fj.05-5243fje (Pubitemid 44943819)
157. Hu P.-F., Tang J.-L., Chen W.-P., Bao J.-P., Wu L.-D., Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients. International Orthopaedics 2011 35 9 1421 1426 2-s2.0-80655133811 10.1007/s00264-010-1100-y
158. di Franco M., Spinelli F. R., Metere A., Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis. Mediators of Inflammation 2012 2012 7 10.1155/2012/347268 347268
159. White R. T., Damm D., Hancock N., Rosen B. S., Lowell B. B., Usher P., Flier J. S., Spiegelman B. M., Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. Journal of Biological Chemistry 1992 267 13 9210 9213 2-s2.0-0026794743
160. Vuolteenaho K., Hannonen P., Kauppi M., Korpela M., Möttönen T., Kaipiainen-Seppänen O., Kautiainen H., Nieminen R., Levälampi T., Leirisalo-Repo M., Predictive value of pretretment adipocytokine levels for remission rates in early RA treated with DMARDS and infliximab. Basic & Clinical Pharmacology & Toxicology 2010 107, supplement 1 133